Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study

  • Efrat Luttwak*
  • , Moshe E. Gatt
  • , Eyal Lebel
  • , Noa Lavi
  • , Tamar Tadmor
  • , Kreiniz Natalia
  • , Noam Benyamini
  • , Netanel Horowitz
  • , Mika Geva
  • , Celia Suriu
  • , Irit Avivi
  • , Svetlana Trestman
  • , Moshe Mittelman
  • , Ory Rouvio
  • , Yael C. Cohen
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry